Life Science Association of Manitoba Newsletter: October 3, 2011

Oct 4, 2011 | Corporate Member News

In this issue:

Member & Local News

  • Governments of Canada and Saskatchewan Support Development of New Environmental Technology 
  • Restructured drug developer Medicure says it has enough revenue to continue   
  • Lilly expands open-innovation efforts with new drug discovery platform  
  • First published papers on IMRIS suites report positive results 

Life Science in the News     

  • U.S. FDA guidance on biosimilars may be imminent 
  • Weyerhaeuser announces participation in jet biofuel research   
  • Biotech investors bow out after approvals as sales hurdles grow 
  • Canadian scientists recognized at this year’s Ig Nobel Prize Ceremony (for achievements that first make people laugh then make them think) 


and more

Access the newsletter here

About the Life Science Association of Manitoba (LSAM): 

LSAM represents all those involved in the Life Science Sector in Manitoba. The Life Science Sector focuses on the use of innovative biological tools and products, the creation of wealth and sustainability in the production of medical treatments, diagnostics, more-nutritional foods, energy, chemicals, and materials, while improving the quality of the environment.

The Life Science sector is a key to economic growth within the Province of Manitoba and is currently estimated to contribute more than 7% of the province’s GDP. In addition to generating value on its own, the Life Science sector is helping to grow and sustain competitiveness in ailing and traditional sectors of the economy, through the application of new and innovative products and processes. 

To find out more about LSAM visit its website here

Similar Posts


advertisement advertisement


Thank you @MEIAmb for inviting @mbchambersofcom to participate in 2022 Emerging Issues Cleantech Conference where we shared information on our Climate Action Toolkit for MB Businesses that can be found at #VoiceofBusiness #PoweroftheNetwork